USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an antiāIL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.